Not Yet RecruitingNot Applicable

Herbs & Supplements in Breast Cancer Usage, Impact, and Personalized Approaches for Diverse Populations

United States240 participantsStarted 2026-06

Plain-language summary

This research study is enrolling participants diagnosed with breast cancer and receiving/received chemotherapy and/or endocrine therapy. The study's primary objective is to assess the differences in the use of herbs and supplements among the populations served at Cleveland Clinic Florida and Ohio by administering a participant-reported questionnaire.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age: 18 years and older. * Breast cancer diagnosis at pathologic stage (I, II, and III) * Participants with regional lymph node involvement * Received Chemotherapy and/ or Endocrine therapy * Established patients followed by a medical oncologist at Cleveland Clinic Florida and Ohio * Able and willing to participate in the one-time survey. Exclusion Criteria: * Under 18 years of age * Prior history of cancer diagnosis * Unable or unwilling to participate in the survey * Distant Metastatic Disease

What they're measuring

Influence of ethnicity on herb/supplement usage among early stage breast cancer participants.

Timeframe: 5 months

Trial details

NCT IDNCT06926530

SponsorCase Comprehensive Cancer Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-03

Contact for this trial

Elizabeth Stone, MD

954-659-5840 stonee@ccf.org

View on ClinicalTrials.gov More Breast Cancer trials